Fine-tuning the encapsulation of a photosensitizer in nanoparticles reveals the relationship between internal structure and phototherapeutic effects.


Journal

Journal of biophotonics
ISSN: 1864-0648
Titre abrégé: J Biophotonics
Pays: Germany
ID NLM: 101318567

Informations de publication

Date de publication:
03 2023
Historique:
revised: 07 07 2022
received: 19 04 2022
accepted: 27 08 2022
pubmed: 3 9 2022
medline: 15 3 2023
entrez: 2 9 2022
Statut: ppublish

Résumé

Photodynamic therapy (PDT) is a cancer therapy that uses a photosensitizer (PS) in the presence of oxygen molecules. Since singlet oxygen is highly reactive, it is important to deliver it to the target site. Thus, an efficient drug delivery system (DDS) is essential for enhancing the efficacy of such a treatment and protecting against the side effects of PDT. Here, we report on attempts to increase the therapeutic effect of PDT by using a DDS, a lipid nanoparticle (LNP). We prepared a porphyrin analog, rTPA (PS) that was encapsulated in LNPs using a microfluidic device. The findings indicated that the internal structure of the prepared particles changed depending on the amount of rTPA in LNPs. The photoactivity and cell-killing effect of PS in LNPs also changed when the amount of the cargo increased. These results suggest that the internal structure of LNPs is important factors that affect drug efficacy.

Identifiants

pubmed: 36054273
doi: 10.1002/jbio.202200119
doi:

Substances chimiques

Photosensitizing Agents 0
Singlet Oxygen 17778-80-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202200119

Subventions

Organisme : Grant-in-Aids for Scientific Research
ID : 20H04523
Organisme : Grant-in-Aids for Scientific Research
ID : 21H0175301
Organisme : Scientific Research on Innovative Area
ID : 21K19036
Organisme : Special Education and Research Expenses of the MEXT
ID : JPMJPR19K8

Informations de copyright

© 2022 The Authors. Journal of Biophotonics published by Wiley-VCH GmbH.

Références

S. Kwiatkowski, B. Knap, D. Przystupski, J. Saczko, E. Kedzierska, K. Knap-Czop, J. Kotlinska, O. Michel, K. Kotowski, J. Kulbacka, Biomed. Pharmacother. 2018, 106, 1098.
J. S. Dysart, M. S. Patterson, Phys Med Biol 2005, 50, 2597.
Y. Zheng, Z. Li, H. Chen, Y. Gao, Eur. J. Pharm. Sci. 2020, 144, 105213.
S. Sansaloni-Pastor, J. Bouilloux, N. Lange, Pharmaceuticals (Basel) 2019, 12, 148.
S. A. Gerhardt, J. W. Lewis, J. Z. Zhang, R. Bonnett, K. A. McManus, Photochem. Photobiol. Sci. 2003, 2, 934.
W. D. Jang, N. Nishiyama, G. D. Zhang, A. Harada, D. L. Jiang, S. Kawauchi, Y. Morimoto, M. Kikuchi, H. Koyama, T. Aida, K. Kataoka, Angew Chem Int Ed Engl 2005, 44, 419.
Y. Yamada, H. Akita, H. Kamiya, K. Kogure, T. Yamamoto, Y. Shinohara, K. Yamashita, H. Kobayashi, H. Kikuchi, H. Harashima, Biochim. Biophys. Acta 2008, 1778, 423.
Y. Yamada, Y. Takano, Satrialdi, J. Abe, M. Hibino, H. Harashima, Biomolecules 2020, 10, E83.
Y. Yamada, Y. Sato, T. Nakamura, H. Harashima, J. Controlled Release 2020, 327, 533.
Y. Yamada, M. Satrialdi, D. Hibino, J. Sasaki, H. H. Abe, Adv. Drug Delivery Rev. 2020, 154-155, 187.
Y. Yamada, S. Daikuhara, A. Tamura, K. Nishida, N. Yui, H. Harashima, Chem. Commun. 2019, 55, 7203.
E. Kawamura, M. Hibino, H. Harashima, Y. Yamada, Mitochondrion 2019, 49, 178.
E. Kawamura, M. Maruyama, J. Abe, A. Sudo, A. Takeda, S. Takada, T. Yokota, S. Kinugawa, H. Harashima, Y. Yamada, Mol Ther Nucleic Acids 2020, 20, 687.
Y. Yamada, K. Somiya, A. Miyauchi, H. Osaka, H. Harashima, Sci. Rep. 2020, 10, 7511.
Y. Yamada, M. Maruyama, T. Kita, S. I. Usami, S. I. Kitajiri, H. Harashima, Mitochondrion 2020, 55, 134.
T. Katayama, S. Kinugawa, S. Takada, T. Furihata, A. Fukushima, T. Yokota, T. Anzai, M. Hibino, H. Harashima, Y. Yamada, Mitochondrion 2019, 49, 66.
M. Hibino, Y. Yamada, N. Fujishita, Y. Sato, M. Maeki, M. Tokeshi, H. Harashima, J. Pharm. Sci. 2019, 108, 2668.
X. Li, Y. Zhao, T. Zhang, D. Xing, Adv. Healthcare Mater. 2021, 10, e2001240.
R. Satrialdi, V. Munechika, Y. Biju, H. Takano, Y. Harashima, Chem. Commun. 2020, 56, 1145.
C. Liu, Q. Feng, J. Sun, Adv. Mater. 2019, 31, e1804788.
A. K. Leung, Y. Y. Tam, S. Chen, I. M. Hafez, P. R. Cullis, J Phys Chem B 2015, 119, 8698.
Y. Takano, T. Numata, K. Fujishima, K. Miyake, K. Nakao, W. D. Grove, R. Inoue, M. Kengaku, S. Sakaki, Y. Mori, T. Murakami, H. Imahori, Chem. Sci. 2016, 7, 3331.
N. Hoshyar, S. Gray, H. Han, G. Bao, Nanomedicine (Lond) 2016, 11, 673.
J. Gabrielsson, A. R. Green, J Pharmacol Exp Ther 2009, 331, 767.
N. M. Belliveau, J. Huft, P. J. Lin, S. Chen, A. K. Leung, T. J. Leaver, A. W. Wild, J. B. Lee, R. J. Taylor, Y. K. Tam, C. L. Hansen, P. R. Cullis, Mol Ther Nucleic Acids 2012, 1, e37.

Auteurs

Fumika Kubota (F)

Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Pharmaceutics Research Group, School of Pharmacy, Institut Teknologi Bandung, Bandung, Indonesia.

Yuta Takano (Y)

Research Institute for Electronic Science, Hokkaido University, Sapporo, Japan.

Masatoshi Maeki (M)

Faculty of Engineering, Hokkaido University, Sapporo, Japan.

Manabu Tokeshi (M)

Faculty of Engineering, Hokkaido University, Sapporo, Japan.

Hideyoshi Harashima (H)

Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.

Yuma Yamada (Y)

Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.

Articles similaires

Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Tumor Microenvironment Nanoparticles Immunotherapy Cellular Senescence Animals

Necroptosis as a consequence of photodynamic therapy in tumor cells.

Álvaro Carneiro de Souza, André Luiz Mencalha, Adenilson de Souza da Fonseca et al.
1.00
Photochemotherapy Humans Necroptosis Neoplasms Photosensitizing Agents
Cobalt Azo Compounds Ferric Compounds Polyesters Photolysis

Classifications MeSH